Light-Regulated NO Release as a Novel Strategy To Overcome Doxorubicin Multidrug Resistance

[Image: see text] Nitric oxide (NO) release from a suitable NO photodonor (NOP) can be fine-tuned by visible light stimuli at doses that are not toxic to cells but that inhibit several efflux pumps; these are mainly responsible for the multidrug resistance of the anticancer agent doxorubicin (DOX)....

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:ACS Med Chem Lett
Autors principals: Chegaev, Konstantin, Fraix, Aurore, Gazzano, Elena, Abd-Ellatef, Gamal Eldein F., Blangetti, Marco, Rolando, Barbara, Conoci, Sabrina, Riganti, Chiara, Fruttero, Roberta, Gasco, Alberto, Sortino, Salvatore
Format: Artigo
Idioma:Inglês
Publicat: American Chemical Society 2017
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5346994/
https://ncbi.nlm.nih.gov/pubmed/28337331
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acsmedchemlett.7b00016
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars